CARDIFF ONCOLOGY, INC. License and Services Revenue (Deprecated 2018-01-31)
CARDIFF ONCOLOGY, INC. (CRDF) reported License and Services Revenue (Deprecated 2018-01-31) of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndServicesRevenue · last filed 2017-03-15
- CARDIFF ONCOLOGY, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2015-12-31 was $0.00.
- CARDIFF ONCOLOGY, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $0.00.
- CARDIFF ONCOLOGY, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2015-06-30 was -$2.17K, a 121.66% decline year-over-year.
- CARDIFF ONCOLOGY, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $2.17K.
- CARDIFF ONCOLOGY, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2016 was $0.00.
- CARDIFF ONCOLOGY, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- CARDIFF ONCOLOGY, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2014 was $10.00K.
- CARDIFF ONCOLOGY, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
| Period end | License and Services Revenue (Deprecated 2018-01-31) 3 month | License and Services Revenue (Deprecated 2018-01-31) 6 month | License and Services Revenue (Deprecated 2018-01-31) 9 month | License and Services Revenue (Deprecated 2018-01-31) 12 month | License and Services Revenue (Deprecated 2018-01-31) 152 month | License and Services Revenue (Deprecated 2018-01-31) 155 month | License and Services Revenue (Deprecated 2018-01-31) 158 month | License and Services Revenue (Deprecated 2018-01-31) 161 month | License and Services Revenue (Deprecated 2018-01-31) 164 month | License and Services Revenue (Deprecated 2018-01-31) 167 month | License and Services Revenue (Deprecated 2018-01-31) 170 month | License and Services Revenue (Deprecated 2018-01-31) 173 month | License and Services Revenue (Deprecated 2018-01-31) 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 | ||||||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $0.00 derived: sum of 2 quarters · filed 2016-03-10 | -$2.17K derived: sum of 3 quarters · filed 2016-03-10 | $0.00 10-K · filed 2016-03-10 | |||||||||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 | -$2.17K derived: sum of 2 quarters · filed 2016-03-10 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2015-06-30 | -$2.17K derived: 10-K 12 month − 3 quarters · filed 2016-03-10 | $0.00 derived: sum of 2 quarters · filed 2016-03-10 | $0.00 derived: sum of 3 quarters · filed 2017-03-15 | $0.00 derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2015-03-31 | $2.17K 10-Q · filed 2015-05-05 | $2.17K derived: sum of 2 quarters · filed 2017-03-15 | $2.17K derived: sum of 3 quarters · filed 2017-03-15 | $12.17K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $10.00K derived: sum of 3 quarters · filed 2017-03-15 | $10.00K 10-K · filed 2017-03-15 | |||||||||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-09 | $10.00K derived: sum of 2 quarters · filed 2015-11-09 | $10.00K 10-Q · filed 2015-11-09 | ||||||||||
| 2014-06-30 | $10.00K 10-Q · filed 2015-08-10 | $10.00K 10-Q · filed 2015-08-10 | |||||||||||
| 2014-03-31 | $1.38M 10-Q · filed 2014-05-12 | ||||||||||||
| 2013-12-31 | $0.00 10-K · filed 2016-03-10 | $1.38M 10-K · filed 2014-03-17 | |||||||||||
| 2013-09-30 | $1.38M 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | $1.38M 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $1.38M 10-Q · filed 2013-05-14 | ||||||||||||
| 2012-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $125.00K derived: sum of 2 quarters · filed 2015-03-12 | $125.00K 10-K · filed 2015-03-12 | $1.38M 10-K · filed 2013-04-01 | |||||||||
| 2012-09-30 | $20.00K 10-Q · filed 2013-11-14 | $20.00K 10-Q · filed 2013-11-14 | $1.38M 10-Q · filed 2012-11-14 | ||||||||||
| 2012-06-30 | $1.36M 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $1.36M 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $10.00K derived: sum of 2 quarters · filed 2014-03-17 | $30.00K 10-K · filed 2014-03-17 | ||||||||||
| 2011-09-30 | $10.00K 10-Q · filed 2012-11-14 | $30.00K 10-Q · filed 2012-11-14 | |||||||||||
| 2011-06-30 | $20.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |